Sort
40,608 grants matching “prostate cancer”
WNT5a/ROR2-Mediated Hippo Pathway Activation in Prostate Cancer
$395,509Steven P. Balk · Beth Israel Deaconess Medical Center · R01 · FY2023 · CA
WNT5a/ROR2-Mediated Hippo Pathway Activation in Prostate Cancer
$395,509Steven P. Balk · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA
Administrative Core
$395,484Brian E Henderson · University Of Southern California · U19 · FY2010 · CA
Exploring Statin Pleiotropic Effects within a Very Large EHR Cohort
$395,483Wei-Qi Wei · Vanderbilt University Medical Center · R01 · FY2020 · HL
PSA SCREENING AND PROSTATE CANCER MORTALITY
$395,271Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2000 · CA
IRE1/XBP1s signaling: a novel essential regulator for bone marrow microenvironmen
$395,164Hongjiao Ouyang · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · CA
Amoeboid Membrane Dynamics in Prostate Cancer
$395,145Michael R Freeman · Boston Children'S Hospital · R01 · FY2011 · CA
Targeting AR and AR-Variants in Castration-Resistant Prostate Cancer
$395,105Chendil Damodaran · Texas A&M University Health Science Ctr · R01 · FY2021 · CA
ALLOGENIC PANCREATIC TUMOR VACCINE CELL LINE
$395,000Johns Hopkins University · R01 · FY2002 · CA
Integrative Somatic and Germline Computational Biology to Redefine Clinical Actionability in Solid Tumors
$394,959Eliezer M Van Allen · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Glutaminase I isoforms as personalized biomarkers of prostate cancer
$394,897Jiaoti Huang · Duke University · R01 · FY2023 · CA
Biostatistics and Computational Biology
$394,896Meredith M Regan · Dana-Farber Cancer Inst · P50 · FY2011 · CA
TROP2 AS A NOVEL DRIVER AND THERAPEUTIC TARGET FOR CASTRATION-RESISTANT PROSTATE CANCER
$394,846The Leland Stanford Junior University · · FY2018 · Department of the Army
Technology Diffusion in Cancer: Geographic Variations, Facilitators, Outcomes, and Costs
$394,825Ya-Chen Tina Shih · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Molecular Analysis of Prostate Tumor-Initiating Cells
$394,805Michael M. Shen · Columbia University Health Sciences · P01 · FY2012 · CA
MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES
$394,792Craig Lee Slingluff · University Of Virginia · R01 · FY2017 · CA
MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES
$394,792Craig Lee Slingluff · University Of Virginia · R01 · FY2015 · CA
MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES
$394,792Craig Lee Slingluff · University Of Virginia · R01 · FY2016 · CA
The Biology of Prostate Stem Cells
$394,769E Lynette Wilson · New York University School Of Medicine · R01 · FY2011 · CA
The Biology of Prostate Stem Cells - Resubmission - 1
$394,769E Lynette Wilson · New York University School Of Medicine · R01 · FY2013 · CA
The Biology of Prostate Stem Cells - Resubmission - 1
$394,769E Lynette Wilson · New York University School Of Medicine · R01 · FY2016 · CA
The Biology of Prostate Stem Cells - Resubmission - 1
$394,769E Lynette Wilson · New York University School Of Medicine · R01 · FY2015 · CA
The Biology of Prostate Stem Cells - Resubmission - 1
$394,769E Lynette Wilson · New York University School Of Medicine · R01 · FY2017 · CA
AR Transgene Model of Prostate Intraepithelial Neoplasia
$394,720Beth Israel Deaconess Medical Center · R01 · FY2005 · DK
AR Transgene Model of Prostate Intraepithelial Neoplasia
$394,720Beth Israel Deaconess Medical Center · R01 · FY2004 · DK